WO2008096372A3 - Process for preparing highly pure ezetimibe using novel intermediates - Google Patents
Process for preparing highly pure ezetimibe using novel intermediates Download PDFInfo
- Publication number
- WO2008096372A3 WO2008096372A3 PCT/IN2008/000072 IN2008000072W WO2008096372A3 WO 2008096372 A3 WO2008096372 A3 WO 2008096372A3 IN 2008000072 W IN2008000072 W IN 2008000072W WO 2008096372 A3 WO2008096372 A3 WO 2008096372A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- highly pure
- ezetimibe
- novel intermediates
- preparing highly
- pure ezetimibe
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
The present invention relates to an industrially advantageous process for the preparation of ezetimibe of formula (I) in high yields by using novel benzyl ester intermediates. The present invention further provides a process for the purification of ezetimibe of formula (I).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN234DE2007 | 2007-02-06 | ||
IN234/DEL/2007 | 2007-02-06 | ||
IN216DE2008 | 2008-01-25 | ||
IN216/DEL/2008 | 2008-01-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008096372A2 WO2008096372A2 (en) | 2008-08-14 |
WO2008096372A3 true WO2008096372A3 (en) | 2010-06-24 |
Family
ID=39682193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000072 WO2008096372A2 (en) | 2007-02-06 | 2008-02-06 | Process for preparing highly pure ezetimibe using novel intermediates |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008096372A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006137080A1 (en) * | 2005-06-22 | 2006-12-28 | Manne Satyanarayana Reddy | Improved process for the preparation of ezetimibe |
EP2128133A1 (en) * | 2008-05-26 | 2009-12-02 | Lek Pharmaceuticals D.D. | Ezetimibe process and composition |
WO2009157019A2 (en) * | 2008-06-23 | 2009-12-30 | Ind-Swift Laboratories Limited | Process for preparing ezetimibe using novel allyl intermediates |
WO2010113175A2 (en) | 2009-04-01 | 2010-10-07 | Matrix Laboratories Ltd | Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe |
CN102531985B (en) * | 2011-04-25 | 2013-12-18 | 开原亨泰制药股份有限公司 | Method for preparing ezetimibe key intermediate |
WO2012155932A1 (en) * | 2011-05-17 | 2012-11-22 | Pharmathen S.A. | Improved process for the preparation of ezetimibe |
CN103373970A (en) * | 2012-04-16 | 2013-10-30 | 重庆圣华曦药业股份有限公司 | Synthetic method for Ezetimibe intermediate |
CN102854274B (en) * | 2012-09-13 | 2017-08-22 | 北京万全德众医药生物技术有限公司 | A kind of method of use liquid chromatography for separating and determining Ezetimibe raw material and its preparation |
CN104356041A (en) * | 2014-11-06 | 2015-02-18 | 成都森科制药有限公司 | Preparation method for Ezetimibe |
CN104447473B (en) * | 2014-11-06 | 2016-11-16 | 成都森科制药有限公司 | The preparation method of Ezetimibe intermediate |
CN106706818B (en) * | 2015-11-13 | 2018-08-03 | 广州骏思知识产权管理咨询有限公司韶关分公司 | A kind of Ezetimibe intermediate optical purity assay method |
CN105541690B (en) * | 2015-12-16 | 2018-08-21 | 江苏恒盛药业有限公司 | A kind of preparation method of aza cyclo-butanone derivatives |
CN107176920B (en) * | 2017-04-19 | 2019-09-20 | 江苏恒盛药业有限公司 | A kind of new technique for synthesizing of ezetimibe |
CN110845384B (en) * | 2019-12-04 | 2021-07-20 | 广东省生物医药技术研究所 | Dissociation method of titanium complex drug and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0720599A1 (en) * | 1993-09-21 | 1996-07-10 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
WO2006137080A1 (en) * | 2005-06-22 | 2006-12-28 | Manne Satyanarayana Reddy | Improved process for the preparation of ezetimibe |
US20070049748A1 (en) * | 2005-08-26 | 2007-03-01 | Uppala Venkata Bhaskara R | Preparation of ezetimibe |
-
2008
- 2008-02-06 WO PCT/IN2008/000072 patent/WO2008096372A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0720599A1 (en) * | 1993-09-21 | 1996-07-10 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
WO2006137080A1 (en) * | 2005-06-22 | 2006-12-28 | Manne Satyanarayana Reddy | Improved process for the preparation of ezetimibe |
US20070049748A1 (en) * | 2005-08-26 | 2007-03-01 | Uppala Venkata Bhaskara R | Preparation of ezetimibe |
Also Published As
Publication number | Publication date |
---|---|
WO2008096372A2 (en) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008096372A3 (en) | Process for preparing highly pure ezetimibe using novel intermediates | |
WO2008089984A3 (en) | Process for the preparation of ezetimibe and derivatives thereof | |
WO2011015522A3 (en) | Process for the manufacture of pharmaceutically active compounds | |
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
WO2009095933A3 (en) | Improved and novel process for the preparation of bosentan | |
WO2010062590A3 (en) | Process for the preparation of protected l-alanine derivatives | |
MY150280A (en) | Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid | |
WO2010099441A3 (en) | Synthesis of molecular sieve ssz-74 using a hydroxide-mediated gel | |
WO2009157019A3 (en) | Process for preparing ezetimibe using novel allyl intermediates | |
WO2009134531A3 (en) | Total synthesis of salinosporamide a and analogs thereof | |
WO2011102640A3 (en) | Method for preparing sitagliptin and amine salt intermediates used therein | |
MX2010009926A (en) | New process for the preparatiion of cyclohexanecarboxylic acid dericatives. | |
MX2010009876A (en) | New process for the preparation of cyclohexanecarboxylic acid derivatives via the corresponding cyclohexanecarboxamide derivative. | |
WO2009116081A3 (en) | An improved process for the preparation of aprepitant | |
WO2010113182A8 (en) | Intermediates in the preparation of 1,4-diphenyl azetidinone | |
NZ598278A (en) | Process for preparing biphenyl imidazole compounds | |
WO2010027889A3 (en) | Process for synthesizing substituted isoquinolines | |
WO2012052939A3 (en) | Preparation of bicyclo[2.2.2]octan-2-one compounds | |
MY147894A (en) | Process for preparing intermediate compound for synthesizing an antiulcerant | |
MX2013004425A (en) | Diastereoselective preparation of bicyclo[2.2.2]octan-2-one compounds. | |
GB0612027D0 (en) | Novel process | |
WO2009141833A3 (en) | An improved process for synthesizing highly pure atomoxetine | |
WO2010007121A3 (en) | Process for producing 1,3,2-dioxaborinane compounds | |
MX2011010934A (en) | Process for the preparation of a biphenyl-2-ylcarbamic acid ester. | |
WO2009087674A3 (en) | Improved process for the preparation of (s)-pregabalin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08710275 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08710275 Country of ref document: EP Kind code of ref document: A2 |